Stay updated on Risankizumab in PsA Patients: Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in PsA Patients: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The 403 error and its study-page breadcrumbs are gone, along with the NIH transition announcement. The page view now shows the site navigation and footer without central content.
    Difference
    2%
    Check dated 2026-11-08T15:19:49.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T16:29:19.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A notice appears at the top of the page announcing an NIH transition from the term “artificial intelligence” to “super intelligence” and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T17:16:57.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The site revision label in the footer changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T22:13:14.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T22:07:40.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error and the Study Documents section has been removed, leaving only the basic header and footer with no downloadable documents.
    Difference
    18%
    Check dated 2026-09-20T22:12:42.000Z thumbnail image

Stay in the know with updates to Risankizumab in PsA Patients: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.